Andrew Barnes

Dr Andy Barnes obtained his BSc (Hons) in Microbiology from Heriot-Watt University, Edinburgh and his PhD from the Medical School, University of Edinburgh. Andy worked for the Scottish Office Agriculture and Fisheries Department and at the Moredun Research Institute, Edinburgh before joining a small Canadian biotech company, Aqua Health Ltd, specialising in vaccines for aquaculture in 1993. In 1999, Aqua Health was bought by Swiss pharmaceutical giant Novartis and Andy worked in their animal health division for 4 years before beginning an academic career at The University of Queensland. Currently in the School of Biological Sciences, Andy’s Aquatic Animal Health Lab researches vaccines for the aquaculture industry and investigates health and immunity in aquatic animals ranging from reef-building corals, through prawns and oysters, to barramundi, stingrays and grouper. Aquaculture vaccines: Research and development of vaccines against bacterial, viral and parasitic conditions in farmed aquatic animals; Comparative immunology: Discovery of immune functional systems in non-model organisms; Host-directed bacterial evolution: How novel bacterial strains arise driven by immune selection

[2026] High‐Throughput Sequencing in Aquaculture Disease Investigations: Challenges and Opportunities for Implementation [2026] The Type III Secretion System plasmid pPHDPT3 of Photobacterium damselae subsp. piscicida is stable in Australian isolates due to conserved non-repetitive genomic architecture [2026] Qualitative insights into vaccine hesitancy among striped catfish (Pangasianodon hypophthalmus) farmers in the Mekong Delta, Vietnam [2025] Physiological and immunological biomarkers of chronic thermal stress in post-smolt Atlantic salmon, Salmo salar [2025] Genomics and serotyping of Tenacibaculum maritimum outbreak isolates from Australia and New Zealand for guided vaccine development and stewardship [2025] Striped catfish (Pangasianodon hypophthalmus) farmers' perspectives on chall